Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells

Oncology Reports

Volumn 33, Issue 6, 2015, Pages 2689-2694

  Aiwei, Yao Borengaser ^a   Behjatolah, Monzavi Karbasi ^a   Hedges, Rebeca A ^a   Rogers, Lora J ^a   Kadlubar, Susan A ^a   Thomas, Kieber Emons ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Adipocytes; Breast cancer; Epithelial mesenchymal transition; Estrogen receptor; Hif1

Indexed keywords

ESTROGEN RECEPTOR ALPHA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PROTEIN TWIST1; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; HIF1A PROTEIN, HUMAN; NUCLEAR PROTEIN; OLR1 PROTEIN, HUMAN; TWIST RELATED PROTEIN 1; TWIST1 PROTEIN, HUMAN;

ADIPOCYTE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CELL HYPOXIA; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; ESTROGEN RECEPTOR ALPHA GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MCF 7 CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; BIOSYNTHESIS; BREAST TUMOR; CELL PROLIFERATION; COMPLICATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MCF-7 CELL LINE; METABOLISM; OBESITY; PATHOLOGY; TUMOR MICROENVIRONMENT;

ADIPOCYTES; BREAST NEOPLASMS; CELL HYPOXIA; CELL PROLIFERATION; COCULTURE TECHNIQUES; EPITHELIAL-MESENCHYMAL TRANSITION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MCF-7 CELLS; NUCLEAR PROTEINS; OBESITY; SCAVENGER RECEPTORS, CLASS E; TRANSFORMING GROWTH FACTOR BETA; TUMOR MICROENVIRONMENT; TWIST-RELATED PROTEIN 1;

EID: 84928893831     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3880     Document Type: Article

References (35)

1. + cells: a new link between proteasome activity and estrogen signaling in breast cancer. Oncogene 29: 1509-1518, 2010.
2. Fox EM, Davis RJ and Shupnik MA: ERbeta in breast cancer - onlooker, passive player, or active protector? Steroids 73: 1039-1051, 2008.
3. Fowler AM and Alarid ET: Amping up estrogen receptors in breast cancer. Breast Cancer Res 9: 305, 2007.
4. Fisher B, Costantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NV, Wolmark N, Wickerham DL, Fisher ER, et al: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320: 479-484, 1989.
5. Leu YW, Yan PS, Fan M, Jin VX, Liu JC, Curran EM, Welshons WV, Wei SH, Davuluri RV, Plass C, et al: Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. Cancer Res 64: 8184-8192, 2004.
6. Ryu K, Park C and Lee Y: Hypoxia-inducible factor 1 alpha represses the transcription of the estrogen receptor alpha gene in human breast cancer cells. Biochem Biophys Res Commun 407: 831-836, 2011.
7. Kurebayashi J, Otsuki T, Moriya T and Sonoo H: Hypoxia reduces hormone responsiveness of human breast cancer cells. Jpn J Cancer Res 92: 1093-1101, 2001.
8. Stoner M, Saville B, Wormke M, Dean D, Burghardt R and Safe S: Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells. Mol Endocrinol 16: 2231-2242, 2002.
9. Yi JM, Kwon HY, Cho JY and Lee YJ: Estrogen and hypoxia regulate estrogen receptor alpha in a synergistic manner. Biochem Biophys Res Commun 378: 842-846, 2009.
10. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, Furukawa S, Tochino Y, Komuro R, Matsuda M, et al: Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56: 901-911, 2007.
11. Rausch ME, Weisberg S, Vardhana P and Tortoriello DV: Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int J Obes 32: 451-463, 2008.
12. Chung S, Yoon IY, Shin YK, Lee CH, Kim JW, Lee T, Choi DJ and Ahn HJ: Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea syndrome. Sleep 30: 997-1001, 2007.
13. Ye J, Gao Z, Yin J and He Q: Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293: E1118-E1128, 2007.
14. Wojtczak L and Schönfeld P: Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophys Acta 1183: 41-57, 1993.
15. Fridlyand LE and Philipson LH: Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes Obes Metab 8: 136-145, 2006.
16. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, et al: Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109: 123-139, 2008.
17. Slattery ML, Sweeney C, Edwards S, Herrick J, Baumgartner K, Wolff R, Murtaugh M, Baumgartner R, Giuliano A and Byers T: Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat 102: 85-101, 2007.
18. Maiti B, Kundranda MN, Spiro TP and Daw HA: The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat 121: 479-483, 2010.
19. Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S, et al: Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 71: 2455-2465, 2011.
20. Wabitsch M, Brenner RE, Melzner I, Braun M, Möller P, Heinze E, Debatin KM and Hauner H: Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord 25: 8-15, 2001.
21. Varma V, Yao-Borengasser A, Bodles AM, Rasouli N, Phanavanh B, Nolen GT, Kern EM, Nagarajan R, Spencer HJ III, Lee MJ, et al: Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabetes 57: 432-439, 2008.
22. Cooney CA, Jousheghany F, Yao-Borengasser A, Phanavanh B, Gomes T, Kieber-Emmons AM, Siegel ER, Suva LJ, Ferrone S, Kieber-Emmons T, et al: Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res 13: R58, 2011.
23. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
24. Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J and Gleadle JM: Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways. J Biol Chem 281: 15215-15226, 2006.
25. Dirat B, Bochet L, Escourrou G, Valet P and Muller C: Unraveling the obesity and breast cancer links: a role for cancer-associated adipocytes? Endocr Dev 19: 45-52, 2010.
26. Dawood S, Broglio K, Gonzalez-Angulo AM, Kau SW, Islam R, Hortobagyi GN and Cristofanilli M: Prognostic value of body mass index in locally advanced breast cancer. Clin Cancer Res 14: 1718-1725, 2008.
27. McTiernan A, Irwin M and Vongruenigen V: Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol 28: 4074-4080, 2010.
28. Creighton CJ, Sada YH, Zhang Y, Tsimelzon A, Wong H, Dave B, Landis MD, Bear HD, Rodriguez A and Chang JC: A gene transcription signature of obesity in breast cancer. Breast Cancer Res Treat 132: 993-1000, 2012.
29. Xu J, Lamouille S and Derynck R: TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19: 156-172, 2009.
30. Liang M, Zhang P and Fu J: Up-regulation of LOX-1 expression by TNF-alpha promotes trans-endothelial migration of MDA-MB-231 breast cancer cells. Cancer Lett 258: 31-37, 2007.
31. Wang R, Ding G, Liang W, Chen C and Yang H: Role of LOX-1 and ROS in oxidized low-density lipoprotein induced epithelial-mesenchymal transition of NRK52E. Lipids Health Dis 9: 120, 2010.
32. Sánchez-Elsner T, Ramírez JR, Sanz-Rodriguez F, Varela E, Bernabéu C and Botella LM: A cross-talk between hypoxia and TGF-beta orchestrates erythropoietin gene regulation through SP1 and Smads. J Mol Biol 336: 9-24, 2004.
33. Chen HC, Zhu YT, Chen SY and Tseng SC: Selective activation of p120ctn-Kaiso signaling to unlock contact inhibition of ARPE-19 cells without epithelial-mesenchymal transition. PLoS One 7: e36864, 2012.
34. Goel HL and Mercurio AM: VEGF targets the tumour cell. Nat Rev Cancer 13: 871-882, 2013.
35. van Uden P, Kenneth NS and Rocha S: Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem J 412: 477-484, 2008.